Raymond James & Associates’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-41,348
| Closed | -$568K | – | 3826 |
|
|
2023
Q1 | $568K | Sell |
41,348
-1,168
| -3% | -$16K | ﹤0.01% | 2823 |
|
|
2022
Q4 | $723K | Buy |
42,516
+1,883
| +5% | +$32K | ﹤0.01% | 2624 |
|
|
2022
Q3 | $924K | Buy |
40,633
+1,900
| +5% | +$43.2K | ﹤0.01% | 2445 |
|
|
2022
Q2 | $698K | Sell |
38,733
-1,334
| -3% | -$24K | ﹤0.01% | 2685 |
|
|
2022
Q1 | $1.07M | Buy |
40,067
+19,067
| +91% | +$510K | ﹤0.01% | 2538 |
|
|
2021
Q4 | $616K | Buy |
21,000
+533
| +3% | +$15.6K | ﹤0.01% | 2929 |
|
|
2021
Q3 | $1.35M | Buy |
20,467
+39
| +0.2% | +$2.57K | ﹤0.01% | 2381 |
|
|
2021
Q2 | $1.7M | Buy |
20,428
+50
| +0.2% | +$4.16K | ﹤0.01% | 2211 |
|
|
2021
Q1 | $1.56M | Sell |
20,378
-335
| -2% | -$25.7K | ﹤0.01% | 2181 |
|
|
2020
Q4 | $1.83M | Sell |
20,713
-10,339
| -33% | -$913K | ﹤0.01% | 1932 |
|
|
2020
Q3 | $2.29M | Sell |
31,052
-250
| -0.8% | -$18.5K | ﹤0.01% | 1663 |
|
|
2020
Q2 | $2.29M | Hold |
31,302
| – | – | ﹤0.01% | 1657 |
|
|
2020
Q1 | $1.76M | Sell |
31,302
-1,304
| -4% | -$73.2K | ﹤0.01% | 1646 |
|
|
2019
Q4 | $1.24M | Buy |
+32,606
| New | +$1.24M | ﹤0.01% | 2140 |
|